ANDRES HUBERMAN: Open Payments
NPI 1063579043 · GREAT NECK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,161 in 43 payments from 8 companies in 2025. Trend: 2023 $1,503 · 2024 $1,174 · 2025 $1,161
Food & beverage: $1,161
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 14 | $312 |
| Janssen Pharmaceuticals, Inc | 6 | $294 |
| Axsome Therapeutics, Inc. | 6 | $167 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $154 |
| ABBVIE INC. | 3 | $71 |
| Corium, LLC | 4 | $70 |
| Supernus Pharmaceuticals, Inc. | 3 | $69 |
| Teva Pharmaceuticals USA, Inc. | 1 | $25 |
Products named: SPRAVATO, REXULTI, Auvelity, TRINTELLIX, ABILIFY MAINTENA, VRAYLAR, Azstarys, Qelbree.
Industry payments across NY — which companies pay providers there.
